<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cureus</journal-id><journal-id journal-id-type="iso-abbrev">Cureus</journal-id><journal-id journal-id-type="issn">2168-8184</journal-id><journal-title-group><journal-title>Cureus</journal-title></journal-title-group><issn pub-type="epub">2168-8184</issn><publisher><publisher-name>Cureus</publisher-name><publisher-loc>Palo Alto (CA)</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11786247</article-id><article-id pub-id-type="doi">10.7759/cureus.76778</article-id><article-categories><subj-group subj-group-type="heading"><subject>Epidemiology/Public Health</subject></subj-group><subj-group><subject>Pediatrics</subject></subj-group><subj-group><subject>Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Age-Stratified Prevalence of Helicobacter pylori Infection in Children With Recurrent Abdominal Pain: A Prospective Observational Study</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Muacevic</surname><given-names>Alexander</given-names></name></contrib><contrib contrib-type="editor"><name><surname>Adler</surname><given-names>John R</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>KR</surname><given-names>Jishnu</given-names></name><xref rid="aff-1" ref-type="aff">1</xref><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Sahu</surname><given-names>Bikash R</given-names></name><xref rid="aff-3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Das</surname><given-names>Mirabai</given-names></name><xref rid="aff-4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Nath</surname><given-names>Preetam</given-names></name><xref rid="aff-5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Biswal</surname><given-names>Seba Ranjan</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Mohakud</surname><given-names>Nirmal K</given-names></name><xref rid="aff-1" ref-type="aff">1</xref><xref rid="aff-6" ref-type="aff">6</xref></contrib></contrib-group><aff id="aff-1">
<label>1</label>
Pediatrics, Kalinga Institute of Medical Sciences, Bhubaneswar, IND </aff><aff id="aff-2">
<label>2</label>
Pediatric Medicine, Assumption Hospital, Sultan Bathery, IND </aff><aff id="aff-3">
<label>3</label>
Zoology, Centurion University of Technology and Management, Bhubaneswar, IND </aff><aff id="aff-4">
<label>4</label>
Health and Education, Kalinga Institute of Social Sciences (KISS), Bhubaneswar, IND </aff><aff id="aff-5">
<label>5</label>
Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND </aff><aff id="aff-6">
<label>6</label>
Infectious Disease, Kalinga Institute of Biotechnology, Bhubaneswar, IND </aff><author-notes><corresp id="cor1">
Nirmal K. Mohakud <email>nirmal.mahakud@kims.ac.in</email>
</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>2</day><month>1</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>1</month><year>2025</year></pub-date><volume>17</volume><issue>1</issue><elocation-id>e76778</elocation-id><history><date date-type="received"><day>11</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>2</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025, KR et al.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>KR et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:href="https://www.cureus.com/articles/327468-age-stratified-prevalence-of-helicobacter-pylori-infection-in-children-with-recurrent-abdominal-pain-a-prospective-observational-study">This article is available from https://www.cureus.com/articles/327468-age-stratified-prevalence-of-helicobacter-pylori-infection-in-children-with-recurrent-abdominal-pain-a-prospective-observational-study</self-uri><abstract><p>Background</p><p>Recurrent abdominal pain (RAP), often considered functional, is a frequent complaint among pediatric patients. However, the increasing availability of advanced diagnostic tools like upper and lower gastrointestinal endoscopy, tests for <italic>Helicobacter pylori</italic>, and abdominal ultrasound have highlighted many organic causes, including <italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) infection, whose prevalence in children remains unclear.</p><p>Objectives</p><p>To determine the age-stratified prevalence of <italic>H. pylori</italic> infection and investigate its role along with other etiologies contributing to RAP&#x000a0;in pediatric patients.</p><p>Methods</p><p>This cross-sectional observational study was conducted between October 2019 and April 2021, involving 60 children aged two to 14 years who met the Rome IV criteria for RAP. Comprehensive evaluations included detailed history-taking, physical examination, and upper gastrointestinal endoscopy with biopsy. Mucosal samples from the antrum were subjected to a rapid urease test (RUT) to detect <italic>H. pylori</italic> infection. The presence of endoscopic abnormalities and their association with positive RUT results were analyzed to identify the underlying causes of RAP.</p><p>Results</p><p><italic>H. pylori </italic>infection was identified in 11 (18.3%) children, with the highest prevalence among children aged seven to 12 years (n=34; 56.7%). All biopsy-positive cases showed concordant rapid urease test results (p=0.001). Organic etiologies were identified in 34 (56.7%) patients, with gastritis and gastric ulcers being the most common findings. Other causes included mesenteric lymphadenitis, urinary tract infections, duodenal ulcers, and hiatus hernia. Children with<italic> H. pylori</italic> infections predominantly exhibited endoscopic abnormalities, underscoring its role in RAP.</p><p>Conclusion</p><p><italic>H. pylori</italic> infection shows a marked increase with age and is a significant organic cause of RAP. Thorough investigations, including endoscopic evaluations, are essential to uncover organic etiologies. Targeted treatment for <italic>H. pylori</italic> should be prioritized in children over seven years presenting with RAP, emphasizing the need for a systematic approach to diagnosing and managing this condition.</p></abstract><kwd-group kwd-group-type="author"><kwd>children</kwd><kwd>gastritis</kwd><kwd>h. pylori</kwd><kwd>rap</kwd><kwd>rapid urease test</kwd><kwd>upper gi endoscopy</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Recurrent abdominal pain (RAP) remains a significant challenge in pediatric practice, being defined in the updated Rome IV criteria as abdominal pain persisting for over two months with at least one weekly episode severe enough to impact the child&#x02019;s daily activities [<xref rid="REF1" ref-type="bibr">1</xref>]. RAP is often regarded as functional (nonorganic), but organic causes are identified in approximately 5-10% of cases [<xref rid="REF2" ref-type="bibr">2</xref>].</p><p>The advent of advanced diagnostic modalities, including gastrointestinal (GI) endoscopy, has substantially enhanced the identification of organic etiologies in children with RAP. For example, abdominal ultrasonography can identify abnormalities in up to 10% of children meeting criteria for further investigation [<xref rid="REF3" ref-type="bibr">3</xref>].&#x000a0;Similarly, innovations in pediatric endoscopy have demonstrated increased diagnostic yields for organic causes of RAP, highlighting the importance of early and precise diagnosis [<xref rid="REF4" ref-type="bibr">4</xref>].</p><p>Epidemiological studies estimate that RAP affects 10-20% of school-aged children globally [<xref rid="REF4" ref-type="bibr">4</xref>,<xref rid="REF5" ref-type="bibr">5</xref>].&#x000a0;Despite this prevalence, the diagnostic challenge persists due to RAP's multifactorial etiopathogenesis, encompassing both organic and functional disorders. Organic causes of RAP include <italic>Helicobacter pylori </italic>(<italic>H. pylori</italic>) infection, parasitic infestations, eosinophilic esophagitis, carbohydrate intolerance, irritable bowel syndrome, and urinary tract infections (UTIs) [<xref rid="REF6" ref-type="bibr">6</xref>,<xref rid="REF7" ref-type="bibr">7</xref>]. Among these, <italic>H. pylori</italic> infection has emerged as an increasingly recognized contributor, with prevalence rates varying by geography, age, and socioeconomic status.</p><p>Clinically, RAP presents as intermittent or continuous abdominal pain, often accompanied by red-flag signs such as weight loss, poor growth, gastrointestinal bleeding, and abdominal tenderness. The presence of these red flags necessitates prompt evaluation using a combination of hematology, biochemistry, imaging studies, and endoscopy [<xref rid="REF2" ref-type="bibr">2</xref>,<xref rid="REF5" ref-type="bibr">5</xref>].&#x000a0;Endoscopic findings frequently reveal gastritis, gastric ulcers, or other abnormalities, particularly in cases involving <italic>H. pylori</italic> [<xref rid="REF3" ref-type="bibr">3</xref>,<xref rid="REF6" ref-type="bibr">6</xref>].</p><p>A comprehensive diagnostic approach should also consider differential diagnoses such as psychogenic factors, carbohydrate malabsorption syndromes, and functional disorders like irritable bowel syndrome (IBS). The incorporation of structured frameworks like the Rome IV criteria aids in distinguishing functional disorders from organic causes [<xref rid="REF1" ref-type="bibr">1</xref>,<xref rid="REF7" ref-type="bibr">7</xref>].</p><p>Management of RAP is tailored to the underlying etiology. Organic causes like <italic>H. pylori</italic> infection warrant antibiotic eradication therapy, whereas functional causes often benefit from dietary modifications, psychological interventions, and reassurance. Complications of untreated RAP include persistent pain, school absenteeism, and impaired quality of life, underscoring the need for timely and accurate diagnosis [<xref rid="REF4" ref-type="bibr">4</xref>,<xref rid="REF6" ref-type="bibr">6</xref>].</p><p>In this study, we aimed to evaluate the clinical characteristics and endoscopic findings in children with RAP to assess the prevalence of <italic>H. pylori</italic> infection and identify other organic causes. By adopting a systematic and comprehensive diagnostic approach, we aim to contribute to the improved management of RAP in pediatric populations.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><p>The study was conducted as a cross-sectional observational investigation at the Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, Odisha, over 18 months, from October 2019 to April 2021. Data were collected at a single point in time for each participant during their clinical evaluation to identify the prevalence of <italic>Helicobacter pylori</italic> infection and other etiologies of recurrent abdominal pain (RAP) in the pediatric population. The design ensured real-time clinical, endoscopic, and histopathological data collection, minimizing recall bias. Ethical approval was obtained from the institutional ethics committee (KIIT/KIMS/IEC/118/2019), in adherence to the principles of the Helsinki Declaration.</p><p>Data collection</p><p>A total of 60 children of either sex, between two and 14 years of age, who fulfilled ROME IV criteria for RAP, both from the outpatient clinic and inpatient wards, were included. The Rome IV criteria for recurrent abdominal pain (RAP) in children require the presence of abdominal pain occurring at least four times per month over at least two months, significantly affecting daily activities, with no evidence of an organic disease after appropriate evaluation [<xref rid="REF8" ref-type="bibr">8</xref>]. Children with a previous endoscopic diagnosis of a gastrointestinal disorder or critically ill children were excluded from the study. A detailed clinical evaluation was done as per the proforma. Hematological and biochemical tests (complete blood count, C-reactive protein, liver function test, renal function test), urine routine, microscopy, culture, and sensitivity, and stool routine, microscopy, culture, and sensitivity, along with ultrasound sonography (USG) abdomen, were done.</p><p>Endoscopic procedure and&#x000a0;<italic>H. pylori</italic>&#x000a0;test</p><p>Upper gastrointestinal endoscopy was performed at the Department of Gastroenterology and Hepatology using an Olympus CLV 190 gastroscope under anesthetic support. For children aged &#x0003e;5 years, a combination of local lignocaine spray, midazolam, and pentazocine was utilized, while for those &#x0003c;5 years, propofol and ketamine (1 mg/kg) were administered under multipara monitoring for vital signs. A rapid urease test (RUT) was performed using a mucosal sample from the antrum.</p><p>To further investigate pathological changes, 4-6 gastric antral mucosal samples were taken using biopsy forceps. The specimens were immediately fixed in 10% buffered formalin to ensure the preservation of tissue integrity. Subsequently, the samples were processed routinely, and slides were stained using hematoxylin and eosin (H&#x00026;E) to evaluate the pathological response to&#x000a0;<italic>H. pylori</italic>.&#x000a0;This standardized approach to RUT and biopsy handling ensures accuracy and reproducibility.</p><p>Statistical analysis</p><p>Data were entered and analyzed using an Excel sheet and IBM SPSS Statistics for Windows, Version 21 (Released 2012; IBM Corp., Armonk, New York, United States) [<xref rid="REF9" ref-type="bibr">9</xref>]. Basic descriptive statistics were performed and displayed as frequency tables.</p></sec><sec sec-type="results"><title>Results</title><p>The mean age of the children was 10.27 &#x000b1; 3.07 years. It was observed that five, 21, and 34 (56.7%) of the patients were in the age groups of two to five years, six to 10 years, and 11-15 years, respectively, and had RAP. The majority of children were males (M:F; 1.85:1). In the study, <italic>H. pylori</italic> positivity showed an increasing trend with age, being highest (72.7%) in the 11-15 years age group, followed by 27.3% in the six to 10 years group and 10.9% in the two to five years group. However, the association between age groups and biopsy results was insignificant (chi-square=3.40, p=0.49) (Table <xref rid="TAB1" ref-type="table">1</xref>).</p><table-wrap position="float" id="TAB1"><label>Table 1</label><caption><title>Age group-wise stratification of H. pylori cases in children aged two to 14 years</title></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="2" colspan="1">Age groups (count % within age group)</td><td colspan="4" rowspan="1">Biopsy</td></tr><tr><td rowspan="1" colspan="1">Positive &#x000a0;</td><td rowspan="1" colspan="1">Negative</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">Total</td></tr><tr style="background-color:#ccc"><td rowspan="2" colspan="1">2- 5 years &#x000a0;</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">5</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">10.9%</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">8.3%</td></tr><tr style="background-color:#ccc"><td rowspan="2" colspan="1">6 to 10 years &#x000a0;</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">21</td></tr><tr><td rowspan="1" colspan="1">27.3%</td><td rowspan="1" colspan="1">34.8%</td><td rowspan="1" colspan="1">66.7%</td><td rowspan="1" colspan="1">35%</td></tr><tr style="background-color:#ccc"><td rowspan="2" colspan="1">11 to 15 years &#x000a0;</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">34</td></tr><tr><td rowspan="1" colspan="1">72.7%</td><td rowspan="1" colspan="1">54.3%</td><td rowspan="1" colspan="1">33.3%</td><td rowspan="1" colspan="1">56.7%</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Total</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">60</td></tr><tr><td colspan="5" rowspan="1">Chi-square-3.40; p-value-0.49; not significant</td></tr></tbody></table></table-wrap><p>Figure <xref rid="FIG1" ref-type="fig">1</xref> provides a breakdown of etiological organic causes identified in the biopsy test of children undergoing investigation for recurrent abdominal pain as part of the study on the prevalence of <italic>Helicobacter pylori (H. pylori)</italic>. Panel A shows the distribution of organic causes as a donut chart, highlighting conditions such as antral gastritis, duodenal ulcers, fundal erosions, esophagitis, and other gastric abnormalities. Most cases were classified as normal (n=30, 65.2%), while smaller proportions had diagnoses such as pangastritis (n=6, 13%) or antral gastritis (n=2, 4.3%). Panel B illustrates the corresponding number of cases for each condition, with the red bars representing the subset positive for <italic>H. pylori</italic>. Significant findings include a notable proportion of <italic>H. pylori</italic>-positive cases in antral gastritis and duodenal ulcer groups, demonstrating a possible association between <italic>H. pylori</italic> infection and these conditions.</p><fig position="anchor" fig-type="figure" id="FIG1"><label>Figure 1</label><caption><title>Breakdown of etiological organic causes identified in the biopsy test in children with recurrent abdominal pain (RAP)</title><p>Panel A: duodenal ulcer, n=4 (6.7%); erosions in fundus, n=7 (11.7%); esophagitis, n=3 (5%); mild antral gastritis, n=2 (3.3%); proximal gastritis, n=1 (1.7%)</p><p>Panel B: corresponding positive for <italic>H. pylori </italic>cases as per etiology.&#x000a0;Duodenal ulcer, n=3 (27.3%); erosions in fundus, n=4 (36.4%)</p></caption><graphic xlink:href="cureus-0017-00000076778-i01" position="float"/></fig><p>The majority of patients had symptoms for three to four months, which varies from six months to two years. <italic>H. pylori </italic>was detected in 11 out of 51 normal USG abdomens (p=0.001) (Table <xref rid="TAB2" ref-type="table">2</xref>). It highlights the comparison between USG abdomen findings and biopsy test results in 60 study subjects. Out of 51 patients with normal USG findings, 11 (100%) were biopsy-positive (p=0.001), while 87% were biopsy-negative. None of the patients with acute appendicitis, colitis, mesenteric adenitis, or mild hepatomegaly were biopsy-positive. Similarly, no biopsy positivity was noted in UTI cases. This data underscores the importance of biopsy in diagnosing significant underlying conditions, particularly in cases with normal USG findings, highlighting its role in evaluating pediatric recurrent abdominal pain.</p><table-wrap position="float" id="TAB2"><label>Table 2</label><caption><title>Comparison of biopsy test according to USG abdomen</title><p>USG: ultrasound sonography; UTI: urinary tract infection</p><p>chi-square value-61.6; *p=0.001</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">&#x000a0;</td><td colspan="3" rowspan="1">Biopsy</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">USG abdomen</td><td rowspan="1" colspan="1">Negative</td><td rowspan="1" colspan="1">Positive</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">Total</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Acute appendicitis</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1 (33.3%)</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">Colitis</td><td rowspan="1" colspan="1">1 (2.2%)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Mesenteric adenitis</td><td rowspan="1" colspan="1">4 (8.7%)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">Mild hepatomegaly</td><td rowspan="1" colspan="1">1 (2.2%)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">40 (87%)</td><td rowspan="1" colspan="1">11<sup>*</sup> (100%)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">51</td></tr><tr><td rowspan="1" colspan="1">UTI</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2 (66.7%)</td><td rowspan="1" colspan="1">2</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Total</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">60</td></tr></tbody></table></table-wrap><p>As shown in Table <xref rid="TAB3" ref-type="table">3</xref>, an increased percentage of patients showing positive biopsy results was observed for antral gastritis, duodenal ulcer, erosions in the fundus, and esophagitis diagnosed by gastrointestinal (GI) endoscopy. However, the majority (30, or 65.2%) of negative patients had normal endoscopic findings. All <italic>H. pylori</italic>-positive cases had erosions or gastritis (p=0.001). The rapid urease test showed a positive result in all biopsy-positive cases (p=0.001).&#x000a0;Table <xref rid="TAB3" ref-type="table">3</xref> reveals that the most common diagnosis among patients was idiopathic recurrent abdominal pain, accounting for 26 cases (43.3%). This was followed by pangastritis in six cases (10%), mesenteric adenitis in three cases (5%), and urinary tract infections in two cases (3.3%).</p><table-wrap position="float" id="TAB3"><label>Table 3</label><caption><title>Comparison of biopsy test according to upper gastrointestinaI endoscopy</title><p>chi-square value-89.66; *p-value=0.001, biopsy not done in three cases</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="2" colspan="1">&#x000a0; Upper gastrointestinal endoscopy</td><td colspan="2" rowspan="1">Biopsy test</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Negative</td><td rowspan="1" colspan="1">Positive</td><td rowspan="1" colspan="1">Total</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Antral gastritis</td><td rowspan="1" colspan="1">2 (4.3%)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2 (3.3%)</td></tr><tr><td rowspan="1" colspan="1">Duodenal ulcer</td><td rowspan="1" colspan="1">1 (2.2%)</td><td rowspan="1" colspan="1">3 (27.3%)</td><td rowspan="1" colspan="1">4 (6.7%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Erosions in fundus</td><td rowspan="1" colspan="1">3 (6.5%)</td><td rowspan="1" colspan="1">4 (36.4%)</td><td rowspan="1" colspan="1">7 (11.7%)</td></tr><tr><td rowspan="1" colspan="1">Esophagitis</td><td rowspan="1" colspan="1">2 (4.3%)</td><td rowspan="1" colspan="1">1 (9.1%)</td><td rowspan="1" colspan="1">3 (5%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Mild antral gastritis</td><td rowspan="1" colspan="1">1 (2.2%)</td><td rowspan="1" colspan="1">1 (9.1%)</td><td rowspan="1" colspan="1">2 (3.3%)</td></tr><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">30 (65.2%)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">30 (50%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Pangastritis</td><td rowspan="1" colspan="1">6 (13%)</td><td rowspan="1" colspan="1">1 (9.1%)</td><td rowspan="1" colspan="1">7 (11.7%)</td></tr><tr><td rowspan="1" colspan="1">Proximal gastritis</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1 (9.1%)</td><td rowspan="1" colspan="1">1 (1.7%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Small hiatus hernia</td><td rowspan="1" colspan="1">1 (2.2%)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1 (1.7%)</td></tr><tr><td rowspan="1" colspan="1">Total</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">11<sup>*</sup>
</td><td rowspan="1" colspan="1">57</td></tr></tbody></table></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>The study highlights significant findings regarding recurrent abdominal pain (RAP) in pediatric patients, emphasizing the association between <italic>Helicobacter pylori (H. pylori) </italic>infection and gastrointestinal pathology. Among patients with normal abdominal ultrasonography (USG), 21.6% tested positive for <italic>H. pylori</italic> on biopsy (p=0.001), suggesting its potential role in RAP. Endoscopic findings demonstrated erosive and inflammatory conditions like duodenal ulcers and fundal erosions strongly associated with biopsy positivity (p=0.001), while biopsy-negative cases showed normal endoscopic findings. These findings underscore the importance of targeted diagnostic evaluations in children with RAP.</p><p>Pain in the abdomen in children can have multiple etiologies. A significant symptom of <italic>H. pylori</italic> infection includes abdominal pain, accompanied by nausea, loss of appetite, burping, and bloating [<xref rid="REF10" ref-type="bibr">10</xref>]. The prevalence of <italic>H. pylori </italic>infection has increased, especially in children, possibly due to underdeveloped immunity, improved diagnostics, and lifestyle changes [<xref rid="REF11" ref-type="bibr">11</xref>-<xref rid="REF13" ref-type="bibr">13</xref>]. Factors such as contaminated restaurant food and a busy lifestyle contribute to its rising prevalence.</p><p>In this study, <italic>H. pylori</italic> infection was most common in children aged seven to 12 years, with prevalence increasing with age from 8.3% in children &#x0003c;5 years to 56.7% in those &#x0003e;11 years. This trend aligns with findings from both developing countries like Saudi Arabia and developed nations like Korea [<xref rid="REF14" ref-type="bibr">14</xref>-<xref rid="REF17" ref-type="bibr">17</xref>]. Immune responses, including heightened regulatory T cell activity and less Th17 activity in children compared to adults, may explain age-related differences in infection and inflammation [<xref rid="REF18" ref-type="bibr">18</xref>].</p><p>Of the 60 children studied, 34 (56.7%) had organic RAP, with <italic>H. pylori</italic> being a major contributor. Contrary to earlier findings from India that dismissed a link between <italic>H. pylori</italic> and RAP, this study found a significant association (p=0.001). Children with <italic>H. pylori</italic> infection benefit from a triple-drug regimen (PPI and two antibiotics) for two weeks, alleviating symptoms in 82% of cases [<xref rid="REF19" ref-type="bibr">19</xref>,<xref rid="REF20" ref-type="bibr">20</xref>].</p><p>The frequency of abdominal pain varied between positive and negative cases. Among <italic>H. pylori</italic>-positive cases, 45.5% experienced pain several times per week, 36.4% once per week, and 18.2% daily, consistent with other studies [<xref rid="REF21" ref-type="bibr">21</xref>,<xref rid="REF22" ref-type="bibr">22</xref>]. Upper abdominal pain was most common in positive cases (54.5%) and aligns with earlier findings linking <italic>H. pylori </italic>to epigastric pain [<xref rid="REF23" ref-type="bibr">23</xref>,<xref rid="REF24" ref-type="bibr">24</xref>].</p><p>Pathological manifestations of <italic>H. pylori</italic>, including gastritis and duodenal ulcers, were evident in endoscopy findings (Figure <xref rid="FIG1" ref-type="fig">1</xref>). These results reaffirm the role of <italic>H. pylori</italic> in RAP and highlight the need for diagnostic confirmation through endoscopy and biopsy, particularly in high-prevalence regions [<xref rid="REF25" ref-type="bibr">25</xref>,<xref rid="REF26" ref-type="bibr">26</xref>].</p><p>Many factors, like dietary habits, socioeconomic status, or environmental conditions, can influence <italic>H. pylori</italic> infection rates. Previous studies have highlighted the significant impact of such variables on <italic>H. pylori</italic> prevalence and associated gastrointestinal disorders, emphasizing the need for their inclusion in future research [<xref rid="REF27" ref-type="bibr">27</xref>,<xref rid="REF28" ref-type="bibr">28</xref>]. Addressing these factors will provide a more comprehensive understanding of disease dynamics and strengthen the evidence base for tailored interventions.</p><p>Limitations</p><p>The study's small sample size (n=60) and cross-sectional design limit its ability to assess causal relationships and long-term outcomes. Factors such as dietary habits, socio-economic status, and environmental exposures were not explored, and the absence of a control group limits generalizability. Future studies with larger samples and longitudinal designs are warranted to validate these findings.</p><p>Implications and suggestions</p><p>These findings emphasize the necessity of adopting a systematic and evidence-based approach to diagnosing RAP, particularly in older children, where the likelihood of organic causes such as <italic>H. pylori</italic> is higher. Early identification and targeted management of <italic>H. pylori</italic> infection have the potential to significantly alleviate symptoms, improve quality of life, and prevent complications associated with chronic gastritis or gastric ulcers. This study advocates for pediatricians to routinely consider endoscopic evaluations and microbiological testing in children presenting with RAP, especially those with persistent or severe symptoms.</p><p>Furthermore, the implications extend beyond clinical diagnosis to broader public health strategies, including addressing dietary habits, improving hygiene practices, and increasing awareness about the potential for treatable organic causes like <italic>H. pylori </italic>infection. Future studies should explore the long-term benefits of eradicating <italic>H. pylori</italic>, assess the role of environmental and socioeconomic factors in infection rates, and establish guidelines for age-specific diagnostic and treatment protocols.&#x000a0;</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Recurrent abdominal pain (RAP) in children remains a challenging condition to diagnose due to its multifactorial etiology, involving both functional and organic causes. Our study highlights the significant role of <italic>Helicobacter pylori (H. pylori)</italic> infection as an under-recognized contributor to RAP, particularly in children aged seven to 12 years. With a prevalence rate of 18.3% in the studied population, <italic>H. pylori</italic> was strongly associated with endoscopic abnormalities such as gastritis and gastric ulcers. Organic causes, including mesenteric lymphadenitis, urinary tract infections, duodenal ulcers, and hiatus hernia, were identified in over half (56.7%) of the children evaluated. Importantly, the use of upper gastrointestinal endoscopy and rapid urease testing demonstrated high efficacy in detecting these underlying organic conditions, reinforcing their role in the diagnostic algorithm for RAP. By integrating advanced diagnostic tools and targeted treatment strategies, we can ensure a paradigm shift in the management of RAP, moving from a symptom-based to a cause-focused approach that will benefit pediatric patients significantly.</p></sec></body><back><ack><p>We want to thank the Department of Pediatrics for their unwavering support and expertise throughout this study. We also sincerely thank the patients and their families for their cooperation and participation, which made this research possible. We acknowledge the Kalinga Institute of Medical Sciences for providing the infrastructure and resources essential for conducting this work.</p></ack><fn-group content-type="conflict"><title>Disclosures</title><fn fn-type="COI-statement"><p><bold>Human subjects:</bold> Consent for treatment and open access publication was obtained or waived by all participants in this study. Institutional Ethics Committee of Kalinga Institute of Medical Sciences issued approval 118/2019.</p><p><bold>Animal subjects:</bold> All authors have confirmed that this study did not involve animal subjects or tissue.</p><p><bold>Conflicts of interest:</bold> In compliance with the ICMJE uniform disclosure form, all authors declare the following:</p><p><bold>Payment/services info:</bold> All authors have declared that no financial support was received from any organization for the submitted work.</p><p><bold>Financial relationships:</bold> All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.</p><p><bold>Other relationships:</bold> All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</p></fn></fn-group><fn-group content-type="other"><title>Author Contributions</title><fn fn-type="other"><p><bold>Concept and design:</bold>&#x000a0; Nirmal K. Mohakud, Preetam Nath</p><p><bold>Acquisition, analysis, or interpretation of data:</bold>&#x000a0; Nirmal K. Mohakud, Mirabai Das, Bikash R. Sahu, Jishnu KR, Seba Ranjan Biswal</p><p><bold>Drafting of the manuscript:</bold>&#x000a0; Nirmal K. Mohakud, Jishnu KR</p><p><bold>Critical review of the manuscript for important intellectual content:</bold>&#x000a0; Nirmal K. Mohakud, Mirabai Das, Bikash R. Sahu, Preetam Nath, Seba Ranjan Biswal</p><p><bold>Supervision:</bold>&#x000a0; Nirmal K. Mohakud, Seba Ranjan Biswal</p></fn></fn-group><ref-list><title>References</title><ref id="REF1"><label>1</label><element-citation publication-type="journal"><article-title>Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions</article-title><source>BMC Gastroenterol</source><person-group>
<name><surname>Edwards</surname><given-names>T</given-names></name>
<name><surname>Friesen</surname><given-names>C</given-names></name>
<name><surname>Schurman</surname><given-names>JV</given-names></name>
</person-group><fpage>41</fpage><volume>18</volume><year>2018</year><pub-id pub-id-type="pmid">29549882</pub-id>
</element-citation></ref><ref id="REF2"><label>2</label><element-citation publication-type="journal"><article-title>Recurrent abdominal pain in children</article-title><source>Am Fam Physician</source><person-group>
<name><surname>Reust</surname><given-names>CE</given-names></name>
<name><surname>Williams</surname><given-names>A</given-names></name>
</person-group><fpage>785</fpage><lpage>793</lpage><volume>97</volume><year>2018</year><uri xlink:href="https://www.aafp.org/pubs/afp/issues/2018/0615/p785.pdf">https://www.aafp.org/pubs/afp/issues/2018/0615/p785.pdf</uri><pub-id pub-id-type="pmid">30216016</pub-id>
</element-citation></ref><ref id="REF3"><label>3</label><element-citation publication-type="journal"><article-title>Recurrent abdominal pain and upper gastrointestinal endoscopy findings in children and adolescents presenting at the Lagos University Teaching Hospital</article-title><source>PLoS One</source><person-group>
<name><surname>Adeniyi</surname><given-names>OF</given-names></name>
<name><surname>Odeghe</surname><given-names>EA</given-names></name>
<name><surname>Lawal</surname><given-names>MA</given-names></name>
<name><surname>Olowu</surname><given-names>AO</given-names></name>
<name><surname>Ademuyiwa</surname><given-names>A</given-names></name>
</person-group><fpage>0</fpage><volume>14</volume><year>2019</year></element-citation></ref><ref id="REF4"><label>4</label><element-citation publication-type="journal"><article-title>Prevalence of pediatric functional gastrointestinal disorders utilizing the Rome IV criteria</article-title><source>J Pediatr</source><person-group>
<name><surname>Robin</surname><given-names>SG</given-names></name>
<name><surname>Keller</surname><given-names>C</given-names></name>
<name><surname>Zwiener</surname><given-names>R</given-names></name>
<etal/>
</person-group><fpage>134</fpage><lpage>139</lpage><volume>195</volume><year>2018</year><pub-id pub-id-type="pmid">29398057</pub-id>
</element-citation></ref><ref id="REF5"><label>5</label><element-citation publication-type="journal"><article-title>Epidemiology of functional gastrointestinal disorders in children and adolescents: a systematic review</article-title><source>World J Gastroenterol</source><person-group>
<name><surname>Boronat</surname><given-names>AC</given-names></name>
<name><surname>Ferreira-Maia</surname><given-names>AP</given-names></name>
<name><surname>Matijasevich</surname><given-names>A</given-names></name>
<name><surname>Wang</surname><given-names>YP</given-names></name>
</person-group><fpage>3915</fpage><lpage>3927</lpage><volume>23</volume><year>2017</year><pub-id pub-id-type="pmid">28638232</pub-id>
</element-citation></ref><ref id="REF6"><label>6</label><element-citation publication-type="journal"><article-title>Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children</article-title><source>J Pediatr Gastroenterol Nutr</source><person-group>
<name><surname>Koletzko</surname><given-names>S</given-names></name>
<name><surname>Jones</surname><given-names>NL</given-names></name>
<name><surname>Goodman</surname><given-names>KJ</given-names></name>
<etal/>
</person-group><fpage>230</fpage><lpage>243</lpage><volume>53</volume><year>2011</year><pub-id pub-id-type="pmid">21558964</pub-id>
</element-citation></ref><ref id="REF7"><label>7</label><element-citation publication-type="journal"><article-title>Helicobacter pylori infection and childhood recurrent abdominal pain: lack of evidence for a cause and effect relationship</article-title><source>Can J Gastroenterol</source><person-group>
<name><surname>Macarthur</surname><given-names>C</given-names></name>
</person-group><fpage>607</fpage><lpage>610</lpage><volume>13</volume><year>1999</year><pub-id pub-id-type="pmid">10519960</pub-id>
</element-citation></ref><ref id="REF8"><label>8</label><element-citation publication-type="journal"><article-title>Childhood functional gastrointestinal disorders: child/adolescent</article-title><source>Gastroenterology</source><person-group>
<name><surname>Hyams</surname><given-names>JS</given-names></name>
<name><surname>Di Lorenzo</surname><given-names>C</given-names></name>
<name><surname>Saps</surname><given-names>M</given-names></name>
<name><surname>Shulman</surname><given-names>RJ</given-names></name>
<name><surname>Staiano</surname><given-names>A</given-names></name>
<name><surname>van Tilburg</surname><given-names>M</given-names></name>
</person-group><fpage>1456</fpage><lpage>1468</lpage><volume>150</volume><year>2016</year></element-citation></ref><ref id="REF9"><label>9</label><element-citation publication-type="webpage"><article-title>SPSS Statistics 21.0 Available for Download</article-title><date-in-citation content-type="access-date">
<month>11</month>
<year>2024</year>
</date-in-citation><year>2012</year><uri xlink:href="https://www.ibm.com/support/pages/spss-statistics-210-available-download">https://www.ibm.com/support/pages/spss-statistics-210-available-download</uri></element-citation></ref><ref id="REF10"><label>10</label><element-citation publication-type="book"><article-title>Symptoms of Acute and Chronic H. pylori Infection</article-title><source>Nayoung Kim</source><person-group>
<name><surname>Kim</surname><given-names>N</given-names></name>
</person-group><fpage>205</fpage><lpage>213</lpage><publisher-loc>Singapore</publisher-loc><publisher-name>Springer</publisher-name><year>2024</year><uri xlink:href="https://link.springer.com/chapter/10.1007/978-981-97-0013-4_16">https://link.springer.com/chapter/10.1007/978-981-97-0013-4_16</uri></element-citation></ref><ref id="REF11"><label>11</label><element-citation publication-type="journal"><article-title>Immune responses to Helicobacter pylori infection</article-title><source>World J Gastroenterol</source><person-group>
<name><surname>Moyat</surname><given-names>M</given-names></name>
<name><surname>Velin</surname><given-names>D</given-names></name>
</person-group><fpage>5583</fpage><lpage>5593</lpage><volume>20</volume><year>2014</year><pub-id pub-id-type="pmid">24914318</pub-id>
</element-citation></ref><ref id="REF12"><label>12</label><element-citation publication-type="journal"><article-title>Helicobacter pylori infection - recent developments in diagnosis</article-title><source>World J Gastroenterol</source><person-group>
<name><surname>Lopes</surname><given-names>AI</given-names></name>
<name><surname>Vale</surname><given-names>FF</given-names></name>
<name><surname>Oleastro</surname><given-names>M</given-names></name>
</person-group><fpage>9299</fpage><lpage>9313</lpage><volume>20</volume><year>2014</year><pub-id pub-id-type="pmid">25071324</pub-id>
</element-citation></ref><ref id="REF13"><label>13</label><element-citation publication-type="journal"><article-title>Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years</article-title><source>BMC Gastroenterol</source><person-group>
<name><surname>Lim</surname><given-names>SH</given-names></name>
<name><surname>Kwon</surname><given-names>JW</given-names></name>
<name><surname>Kim</surname><given-names>N</given-names></name>
<etal/>
</person-group><fpage>104</fpage><volume>13</volume><year>2013</year><uri xlink:href="http://file:///C:/Users/lenovo/Downloads/1471-230X-13-104.pdf">http://file:///C:/Users/lenovo/Downloads/1471-230X-13-104.pdf</uri><pub-id pub-id-type="pmid">23800201</pub-id>
</element-citation></ref><ref id="REF14"><label>14</label><element-citation publication-type="journal"><article-title>Helicobacter pylori and infantile colic</article-title><source>Arch Pediatr Adolesc Med</source><person-group>
<name><surname>Ali</surname><given-names>AM</given-names></name>
</person-group><fpage>648</fpage><lpage>650</lpage><volume>166</volume><year>2012</year><pub-id pub-id-type="pmid">22751879</pub-id>
</element-citation></ref><ref id="REF15"><label>15</label><element-citation publication-type="journal"><article-title>Changing prevalence of Helicobacter pylori infections in Korean children with recurrent abdominal pain</article-title><source>Pediatr Gastroenterol Hepatol Nutr</source><person-group>
<name><surname>Jang</surname><given-names>KM</given-names></name>
<name><surname>Choe</surname><given-names>BH</given-names></name>
<name><surname>Choe</surname><given-names>JY</given-names></name>
<etal/>
</person-group><fpage>10</fpage><lpage>16</lpage><volume>18</volume><year>2015</year><pub-id pub-id-type="pmid">25866728</pub-id>
</element-citation></ref><ref id="REF16"><label>16</label><element-citation publication-type="journal"><article-title>Changing prevalence of Helicobacter pylori infection in children and adolescents</article-title><source>Clin Exp Pediatr</source><person-group>
<name><surname>Park</surname><given-names>JS</given-names></name>
<name><surname>Jun</surname><given-names>JS</given-names></name>
<name><surname>Seo</surname><given-names>JH</given-names></name>
<name><surname>Youn</surname><given-names>HS</given-names></name>
<name><surname>Rhee</surname><given-names>KH</given-names></name>
</person-group><fpage>21</fpage><lpage>25</lpage><volume>64</volume><year>2021</year><pub-id pub-id-type="pmid">32668822</pub-id>
</element-citation></ref><ref id="REF17"><label>17</label><element-citation publication-type="journal"><article-title>Helicobacter pylori infection in Saudi children; clinical, endoscopic and pathological findings</article-title><source>Arab Journal of Gastroenterology</source><person-group>
<name><surname>Saadah</surname><given-names>OI</given-names></name>
</person-group><fpage>39</fpage><lpage>43</lpage><volume>11</volume><year>2010</year></element-citation></ref><ref id="REF18"><label>18</label><element-citation publication-type="journal"><article-title>Comparative immune response in children and adults with H. pylori infection</article-title><source>J Immunol Res</source><person-group>
<name><surname>Razavi</surname><given-names>A</given-names></name>
<name><surname>Bagheri</surname><given-names>N</given-names></name>
<name><surname>Azadegan-Dehkordi</surname><given-names>F</given-names></name>
<name><surname>Shirzad</surname><given-names>M</given-names></name>
<name><surname>Rahimian</surname><given-names>G</given-names></name>
<name><surname>Rafieian-Kopaei</surname><given-names>M</given-names></name>
<name><surname>Shirzad</surname><given-names>H</given-names></name>
</person-group><fpage>315957</fpage><volume>2015</volume><year>2015</year><pub-id pub-id-type="pmid">26495322</pub-id>
</element-citation></ref><ref id="REF19"><label>19</label><element-citation publication-type="journal"><article-title>Helicobacter pylori in children: an Indian perspective</article-title><source>Indian Pediatr</source><person-group>
<name><surname>Poddar</surname><given-names>U</given-names></name>
<name><surname>Yachha</surname><given-names>SK</given-names></name>
</person-group><fpage>761</fpage><lpage>770</lpage><volume>44</volume><year>2007</year><uri xlink:href="https://www.indianpediatrics.net/oct2007/oct-761-770.htm">https://www.indianpediatrics.net/oct2007/oct-761-770.htm</uri><pub-id pub-id-type="pmid">17998576</pub-id>
</element-citation></ref><ref id="REF20"><label>20</label><element-citation publication-type="journal"><article-title>Helicobacter pylori infection, histopathological gastritis and gastric epithelial cell apoptosis in children</article-title><source>Acta Paediatr</source><person-group>
<name><surname>Singh</surname><given-names>M</given-names></name>
<name><surname>Prasad</surname><given-names>KN</given-names></name>
<name><surname>Krishnani</surname><given-names>N</given-names></name>
<name><surname>Saxena</surname><given-names>A</given-names></name>
<name><surname>Yachha</surname><given-names>SK</given-names></name>
</person-group><fpage>732</fpage><lpage>737</lpage><volume>95</volume><year>2006</year><pub-id pub-id-type="pmid">16754556</pub-id>
</element-citation></ref><ref id="REF21"><label>21</label><element-citation publication-type="journal"><article-title>Recurrent pain abdomen among children- an emphasis on base line investigations</article-title><source>International Journal of Contemporary Medical Research</source><person-group>
<name><surname>Saraswat</surname><given-names>S</given-names></name>
<name><surname>Mohanty</surname><given-names>S</given-names></name>
</person-group><fpage>2419</fpage><lpage>2422</lpage><volume>3</volume><year>2016</year><uri xlink:href="https://www.ijcmr.com/uploads/7/7/4/6/77464738/ijcmr_840_aug_12.pdf">https://www.ijcmr.com/uploads/7/7/4/6/77464738/ijcmr_840_aug_12.pdf</uri></element-citation></ref><ref id="REF22"><label>22</label><element-citation publication-type="journal"><article-title>Childhood recurrent abdominal pain and Helicobacter pylori infection, Islamic Republic of Iran</article-title><source>East Mediterr Health J</source><person-group>
<name><surname>Alimohammadi</surname><given-names>H</given-names></name>
<name><surname>Fouladi</surname><given-names>N</given-names></name>
<name><surname>Salehzadeh</surname><given-names>F</given-names></name>
<name><surname>Alipour</surname><given-names>SA</given-names></name>
<name><surname>Javadi</surname><given-names>MS</given-names></name>
</person-group><fpage>860</fpage><lpage>864</lpage><volume>22</volume><year>2017</year><uri xlink:href="https://iris.who.int/handle/10665/260286">https://iris.who.int/handle/10665/260286</uri><pub-id pub-id-type="pmid">28181660</pub-id>
</element-citation></ref><ref id="REF23"><label>23</label><element-citation publication-type="journal"><article-title>Helicobacter pylori infections in children</article-title><source>Antibiotics (Basel)</source><person-group>
<name><surname>Nguyen</surname><given-names>J</given-names></name>
<name><surname>Kotilea</surname><given-names>K</given-names></name>
<name><surname>Bontems</surname><given-names>P</given-names></name>
<name><surname>Miendje Deyi</surname><given-names>VY</given-names></name>
</person-group><fpage>12</fpage><volume>12</volume><year>2023</year></element-citation></ref><ref id="REF24"><label>24</label><element-citation publication-type="journal"><article-title>Clinical dilemmas for the diagnosis and treatment of Helicobacter pylori infection in children: from guideline to practice</article-title><source>Pediatr Gastroenterol Hepatol Nutr</source><person-group>
<name><surname>Van Veen</surname><given-names>SJ</given-names></name>
<name><surname>Levy</surname><given-names>EI</given-names></name>
<name><surname>Huysentruyt</surname><given-names>K</given-names></name>
<name><surname>Vandenplas</surname><given-names>Y</given-names></name>
</person-group><fpage>267</fpage><lpage>273</lpage><volume>27</volume><year>2024</year><pub-id pub-id-type="pmid">39319281</pub-id>
</element-citation></ref><ref id="REF25"><label>25</label><element-citation publication-type="journal"><article-title>Helicobacter pylori infection: clinical, endoscopic, and histological findings in Lebanese pediatric patients</article-title><source>Int J Pediatr</source><person-group>
<name><surname>Al Kirdy</surname><given-names>F</given-names></name>
<name><surname>Rajab</surname><given-names>M</given-names></name>
<name><surname>El-Rifai</surname><given-names>N</given-names></name>
</person-group><fpage>4648167</fpage><volume>2020</volume><year>2020</year><pub-id pub-id-type="pmid">32454839</pub-id>
</element-citation></ref><ref id="REF26"><label>26</label><element-citation publication-type="journal"><article-title>Potential complications of Helicobacter pylori infection in children of a non-urban community</article-title><source>Arch Pediatr Infect Dis</source><person-group>
<name><surname>Ali</surname><given-names>AM</given-names></name>
<name><surname>Elkhatib</surname><given-names>WF</given-names></name>
</person-group><fpage>0</fpage><volume>3</volume><year>2015</year></element-citation></ref><ref id="REF27"><label>27</label><element-citation publication-type="journal"><article-title>The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis</article-title><source>Lancet Child Adolesc Health</source><person-group>
<name><surname>Yuan</surname><given-names>C</given-names></name>
<name><surname>Adeloye</surname><given-names>D</given-names></name>
<name><surname>Luk</surname><given-names>TT</given-names></name>
<etal/>
</person-group><fpage>185</fpage><lpage>194</lpage><volume>6</volume><year>2022</year><pub-id pub-id-type="pmid">35085494</pub-id>
</element-citation></ref><ref id="REF28"><label>28</label><element-citation publication-type="journal"><article-title>Epidemiology of Helicobacter pylori infection among Iranian children</article-title><source>Arab J Gastroenterol</source><person-group>
<name><surname>Ghasemi-Kebria</surname><given-names>F</given-names></name>
<name><surname>Ghaemi</surname><given-names>E</given-names></name>
<name><surname>Azadfar</surname><given-names>S</given-names></name>
<name><surname>Roshandel</surname><given-names>G</given-names></name>
</person-group><fpage>169</fpage><lpage>172</lpage><volume>14</volume><year>2013</year><pub-id pub-id-type="pmid">24433647</pub-id>
</element-citation></ref></ref-list></back></article>